Cytoreductive nephrectomy for metastatic renal cell carcinoma

Abstract

Renal cell carcinoma is the most lethal urologic malignancy. Up to 30% of patients with kidney cancer have metastatic disease and 30% of those treated for local or locally advanced disease progress to metastases. Radical nephrectomy is the standard treatment for the management of nondisseminated kidney cancer, but the role of cytoreductive nephrectomy in patients with metastatic disease is controversial.

Keywords

• Cytoreductive nephrectomy
• prognosis
• renal cell carcinoma